Published in Trans R Soc Trop Med Hyg on April 08, 1996
Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species. J Infect Dis (2009) 1.26
Science, medicine, and the future: Leishmaniasis. BMJ (2000) 1.06
A rare case of localized mucosal leishmaniasis due to Leishmania infantum in an immunocompetent Italian host. Eur J Epidemiol (2005) 0.79
Concomitant Infection with Leishmania donovani and L. major in Single Ulcers of Cutaneous Leishmaniasis Patients from Sudan. J Trop Med (2014) 0.77
[The leishmaniasis - a parasitel infection as differential diagnosis of malignant tumours of oral mucosa. A case report and review of literature]. Mund Kiefer Gesichtschir (2007) 0.75
Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol (1992) 3.45
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A (1993) 3.40
Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg (1993) 2.93
ELISA for the detection of specific IgM and IgG in human leptospirosis. J Gen Microbiol (1985) 2.55
Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg (1994) 2.45
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology (2000) 2.21
Serodiagnosis of human leptospirosis by enzyme-linked-immunosorrbent-assay (ELISA). Zentralbl Bakteriol A (1980) 2.10
Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health (2001) 2.08
Detection of seven species of pathogenic leptospires by PCR using two sets of primers. J Gen Microbiol (1993) 1.96
Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol (1999) 1.93
Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol (2003) 1.92
Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol (1999) 1.92
rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol (1998) 1.90
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet (2000) 1.86
Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect (2008) 1.66
Development and application of the polymerase chain reaction for the detection and identification of Leishmania parasites in clinical material. Arch Inst Pasteur Tunis (1995) 1.63
Detection of leptospiral DNA by nucleic acid hybridisation with 32P- and biotin-labelled probes. J Med Microbiol (1986) 1.62
Anthropogenic impacts on the distribution and biodiversity of benthic macroinvertebrates and water quality of the Langat River, Peninsular Malaysia. Ecotoxicol Environ Saf (2005) 1.61
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Evaluation of PCR for diagnosis of visceral leishmaniasis. J Clin Microbiol (1997) 1.56
Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi. Int J Tuberc Lung Dis (2002) 1.55
A fast agglutination screening test (FAST) for the detection of anti-Leishmania antibodies. Trans R Soc Trop Med Hyg (2001) 1.53
The alteration of serum potassium level during sample transit. Practitioner (1989) 1.51
DNA hybridization with hardjobovis-specific recombinant probes as a method for type discrimination of Leptospira interrogans serovar hardjo. J Gen Microbiol (1988) 1.47
Distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan. Lepr Rev (1993) 1.47
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun (2001) 1.44
Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol (1995) 1.43
Prolongation of prothrombin time with ivermectin. Lancet (1988) 1.41
High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol (1998) 1.40
Recommendations regarding total daily fluoride intake for Canadians. J Can Dent Assoc (1994) 1.39
[Effort phlebitis of the upper limb. Report of 5 cases]. J Mal Vasc (2001) 1.39
Placement and replacement of restorations in a military population. J Can Dent Assoc (1991) 1.38
Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis. J Clin Microbiol (1998) 1.31
The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg (2011) 1.30
Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans R Soc Trop Med Hyg (1992) 1.30
Retinal changes in adults with cerebral malaria. Ann Trop Med Parasitol (2003) 1.25
Endocytosis and vesicle trafficking during tip growth of root hairs. Protoplasma (2005) 1.24
Characterization of serovars of the genus Leptospira by DNA hybridization with hardjobovis and icterohaemorrhagiae recombinant probes with special attention to serogroup sejroe. J Clin Microbiol (1991) 1.24
Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol (2002) 1.23
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol (2000) 1.23
Comparative classification of Leptospira serovars of the Pomona group by monoclonal antibodies and restriction-endonuclease analysis. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 1.22
Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan. Trans R Soc Trop Med Hyg (1992) 1.22
The use of degenerate primers in conjunction with strain and species oligonucleotides to classify Onchocerca volvulus. Methods Mol Biol (1996) 1.22
Cryptosporidium parvum and Isospora belli infections among patients with and without diarrhoea. East Afr Med J (2003) 1.20
Simple measures are as effective as invasive techniques in the diagnosis of pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis (2009) 1.20
Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg (1999) 1.19
Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection. J Infect (2010) 1.18
The prevalence of HIV infection among burn patients in a burns unit in Malawi and its influence on outcome. Burns (2003) 1.16
Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol (1994) 1.16
Detection of Leptospira interrogans in clinical specimens by in situ hybridization using biotin-labelled DNA probes. J Gen Microbiol (1987) 1.15
Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J Infect Dis (1993) 1.15
Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health (2002) 1.15
Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum. J Clin Microbiol (2000) 1.13
Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum (1999) 1.13
Development and application of 'simple' diagnostic tools for visceral leishmaniasis. Med Microbiol Immunol (2001) 1.12
Chloroquine-resistant Plasmodium falciparum in eastern Sudan. Acta Trop (1989) 1.12
A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol (1993) 1.11
The profile of IgG and IgG subclasses of onchocerciasis patients. Clin Exp Immunol (1992) 1.11
Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke (2005) 1.10
The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol (2002) 1.09
Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1. Neurology (2007) 1.08
Evaluation of the polymerase chain reaction in the diagnosis of cutaneous leishmaniasis due to Leishmania major: a comparison with direct microscopy of smears and sections from lesions. Trans R Soc Trop Med Hyg (1996) 1.07
Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol (2001) 1.07
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin Exp Immunol (1994) 1.06
[Cellular (juvenile) fibroadenoma of the breast. A clinico-pathologic and immunohistochemical study of 7 cases]. Ann Pathol (1994) 1.06
Global oral health inequalities: dental caries task group--research agenda. Adv Dent Res (2011) 1.05
Comparison of Giardia isolates from different laboratories by isoenzyme analysis and recombinant DNA probes. Parasitol Res (1992) 1.04
Siderophore production by the pathogenic yeast, Candida albicans. Biochem Biophys Res Commun (1985) 1.04
Relationship between caregiver's and child's caries prevalence among disadvantaged African Americans. Community Dent Oral Epidemiol (2008) 1.03
Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33). Trop Med Parasitol (1992) 1.03
Is Phlebotomus (Larroussius) orientalis a vector of visceral leishmaniasis in south-west Ethiopia? Acta Trop (1995) 1.02
Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria. Exp Parasitol (2005) 1.02
Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings. Trans R Soc Trop Med Hyg (1991) 1.02
Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan. Trop Med Int Health (1997) 1.02
Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators. Arch Toxicol (2011) 1.01
Cell-mediated immune responses to Plasmodium falciparum purified soluble antigens in sickle-cell trait subjects. Immunol Lett (1990) 1.00
T-cell response in human leishmaniasis. Immunol Lett (1999) 1.00
Antimicrobial effects of psidium guajava extract as one mechanism of its antidiarrhoeal action. Malays J Med Sci (1999) 1.00
Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin Exp Immunol (1999) 1.00
The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC). Clin Exp Immunol (2000) 0.99
Co-trimoxazole in HIV-1 infection. Lancet (1999) 0.99
Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Ann Trop Med Parasitol (1998) 0.99
Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan? Trop Med Int Health (2001) 0.99